Using the maternal serum ADAM12 level 5.45 ug/l as a cut-off value to predict hydatidiform mole (Figure 3), the sensitivity was 100.0% and the false-positive rate was 8.3%; the area under the curve (AUC) was 0.90. Here, ADAM12 is linked to hydatidiform mole.